Periodic-Zone Model Predictive Control for Diurnal Closed-Loop Operation of an Artificial Pancreas

Background: The objective of this research is an artificial pancreas (AP) that performs automatic regulation of blood glucose levels in people with type 1 diabetes mellitus. This article describes a control strategy that performs algorithmic insulin dosing for maintaining safe blood glucose levels over prolonged, overnight periods of time and furthermore was designed with outpatient, multiday deployment in mind. Of particular concern is the prevention of nocturnal hypoglycemia, because during sleep, subjects cannot monitor themselves and may not respond to alarms. An AP intended for prolonged and unsupervised outpatient deployment must strategically reduce the risk of hypoglycemia during times of sleep, without requiring user interaction. Methods: A diurnal insulin delivery strategy based on predictive control methods is proposed. The so-called “periodic-zone model predictive control” (PZMPC) strategy employs periodically time-dependent blood glucose output target zones and furthermore enforces periodically time-dependent insulin input constraints to modulate its behavior based on the time of day. Results: The proposed strategy was evaluated through an extensive simulation-based study and a preliminary clinical trial. Results indicate that the proposed method delivers insulin more conservatively during nighttime than during daytime while maintaining safe blood glucose levels at all times. In clinical trials, the proposed strategy delivered 77% of the amount of insulin delivered by a time-invariant control strategy; specifically, it delivered on average 1.23 U below, compared with 0.31 U above, the nominal basal rate overnight while maintaining comparable, and safe, blood glucose values. Conclusions: The proposed PZMPC algorithm strategically prevents nocturnal hypoglycemia and is considered a significant step toward deploying APs into outpatient environments for extended periods of time in full closed-loop operation.

[1]  Eyal Dassau,et al.  Multi-Zone-MPC: Clinical Inspired Control Algorithm for the Artificial Pancreas , 2011 .

[2]  William S. Levine,et al.  The Control Handbook , 2010 .

[3]  Ahmad Haidar,et al.  Closed-Loop Basal Insulin Delivery Over 36 Hours in Adolescents With Type 1 Diabetes , 2013, Diabetes Care.

[4]  Giovanni Sparacino,et al.  Diabetes: Models, Signals, and Control , 2009 .

[5]  F. Doyle,et al.  Design of the Health Monitoring System for the Artificial Pancreas: Low Glucose Prediction Module , 2012, Journal of diabetes science and technology.

[6]  Eyal Dassau,et al.  Zone Model Predictive Control: A Strategy to Minimize Hyper- and Hypoglycemic Events , 2010, Journal of diabetes science and technology.

[7]  F. Doyle,et al.  Quest for the Artificial Pancreas: Combining Technology with Treatment , 2010, IEEE Engineering in Medicine and Biology Magazine.

[8]  E. Atlas,et al.  Nocturnal glucose control with an artificial pancreas at a diabetes camp. , 2013, The New England journal of medicine.

[9]  R.S. Parker,et al.  A model-based algorithm for blood glucose control in Type I diabetic patients , 1999, IEEE Transactions on Biomedical Engineering.

[10]  Stephen D Patek,et al.  Hypoglycemia Prevention via Pump Attenuation and Red-Yellow-Green “Traffic” Lights Using Continuous Glucose Monitoring and Insulin Pump Data , 2010, Journal of diabetes science and technology.

[11]  C. Cobelli,et al.  In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes , 2009, Journal of diabetes science and technology.

[12]  R. Hovorka Continuous glucose monitoring and closed‐loop systems , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[13]  G. Steil,et al.  Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes , 2006, Diabetes.

[14]  Dale E. Seborg,et al.  Control-Relevant Models for Glucose Control Using A Priori Patient Characteristics , 2012, IEEE Transactions on Biomedical Engineering.

[15]  Ali Cinar,et al.  Hypoglycemia Early Alarm Systems Based On Multivariable Models. , 2013, Industrial & engineering chemistry research.

[16]  Jan M. Maciejowski,et al.  Predictive control : with constraints , 2002 .

[17]  C. Cobelli,et al.  Artificial Pancreas: Past, Present, Future , 2011, Diabetes.

[18]  Eyal Dassau,et al.  Modular artificial beta-cell system: a prototype for clinical research. , 2008, Journal of diabetes science and technology.

[19]  Howard Zisser,et al.  Clinical Hurdles and Possible Solutions in the Implementation of Closed-Loop Control in Type 1 Diabetes Mellitus , 2011, Journal of diabetes science and technology.

[20]  Edgar N. Sánchez,et al.  Inverse optimal neural control of blood glucose level for type 1 diabetes mellitus patients , 2012, J. Frankl. Inst..

[21]  Giuseppe De Nicolao,et al.  Model predictive control of glucose concentration in type I diabetic patients: An in silico trial , 2009, Biomed. Signal Process. Control..

[22]  L. Magni,et al.  Evaluating the Efficacy of Closed-Loop Glucose Regulation via Control-Variability Grid Analysis , 2008, Journal of diabetes science and technology.

[23]  Howard C. Zisser,et al.  A Feedforward-Feedback Glucose Control Strategy for Type 1 Diabetes Mellitus. , 2008, Journal of process control.

[24]  Eyal Dassau,et al.  Modular Artificial β-Cell System: A Prototype for Clinical Research , 2008 .

[25]  K. Turksoy,et al.  Multivariable adaptive closed-loop control of an artificial pancreas without meal and activity announcement. , 2013, Diabetes technology & therapeutics.

[26]  Howard C. Zisser,et al.  Fully Integrated Artificial Pancreas in Type 1 Diabetes , 2012, Diabetes.